Periprosthetic Joint Infection

Results showed patients who had periprosthetic joint infection after total joint arthroplasty may have difficulty performing everyday tasks and returning to work.

The controversy over fixation in the obese patient population undergoing TKA remains unsolved.

ForCast Orthopedics has announced FDA qualified infectious disease product designation for its FC001 periprosthetic joint infection treatment program, according to a press release.

LAS VEGAS — Results presented here showed an implant surface culturing method may identify biofilm on culture-negative periprosthetic joint infections, as well as patterns of growth on total knee prostheses.

LAS VEGAS — Intraosseous vancomycin infusion during total hip arthroplasty was feasible for timely delivery of periprosthetic infection prophylaxis, according to a presenter at the American Academy of Orthopaedic Surgeons Annual Meeting.

Published results showed plasma D-dimer was noninferior to serum C-reactive protein and erythrocyte sedimentation rate in the diagnosis of periprosthetic joint infection.

Result showed intra-articular corticosteroid shoulder injections within 4 weeks of reverse shoulder arthroplasty are associated with increased risks of periprosthetic joint infection at 90-days and 1-year postoperatively.

Results found consistent rates of culture positivity for Cutibacterium during revision shoulder arthroplasty in samples with high bacterial loads, while time to positivity and a strength of positivity helped determine true positives.

A significant complication following total joint arthroplasty, the reported incidence of periprosthetic joint infection ranges from 1% to 2% depending on the involved joint, according to the published literature.

PJI is a dreaded complication of primary and revision total joint arthroplasty, with an estimated incidence of 1% to 2% in primary arthroplasty and up to 10% in revision procedures.